[The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives].
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury; D003276:Contraceptives, Oral / Q000009:adverse effects / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000209:etiology; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*; D014592:Uterine Hemorrhage / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced
D000995:Antitubercular Agents; D003276:Contraceptives, Oral; D012293:Rifampin
Rifampicin und andere Antituberkulotika bei gleichzeitiger oraler Kontrazeption.